道明生物宣布任(ren)命(ming)醫學博(bo)士Roger Sidhu為(wei)首(shou)席(xi)醫療官。Sidhu博(bo)士近期曾(ceng)擔(dan)任(ren)Brooklyn(現為(wei)Eterna)ImmunoTherapeutics(一家基因編輯和細胞治療公(gong)(gong)司)首(shou)席(xi)醫療官，并(bing)推進(jin)多個新型項目。此(ci)前，Sidhu博(bo)士曾(ceng)擔(dan)任(ren)Roivant Sciences執行副總(zong)(zong)裁(cai)兼首(shou)席(xi)醫療官，在(zai)該(gai)公(gong)(gong)司被Gilead的子公(gong)(gong)司Kite收(shou)購前，亦(yi)(yi)曾(ceng)擔(dan)任(ren)Cell Design Labs首(shou)席(xi)醫療官，并(bing)于之(zhi)后擔(dan)任(ren)臨(lin)床(chuang)開發副總(zong)(zong)裁(cai)。Sidhu博(bo)士亦(yi)(yi)曾(ceng)在(zai)Amgen擔(dan)任(ren)多種職務。(醫藥健聞)